- Home
- SNX vs QGEN Comparison
SNX vs QGEN Comparison
Compare SNX & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNX
- QGEN
- Stock Information
- Founded
- SNX 1980
- QGEN 1986
- Country
- SNX United States
- QGEN Netherlands
- Employees
- SNX N/A
- QGEN N/A
- Industry
- SNX Retail: Computer Software & Peripheral Equipment
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SNX Technology
- QGEN Health Care
- Exchange
- SNX Nasdaq
- QGEN Nasdaq
- Market Cap
- SNX 13.3B
- QGEN 10.7B
- IPO Year
- SNX 2003
- QGEN 1996
- Fundamental
- Price
- SNX $153.10
- QGEN $48.23
- Analyst Decision
- SNX Strong Buy
- QGEN Buy
- Analyst Count
- SNX 10
- QGEN 7
- Target Price
- SNX $169.00
- QGEN $50.68
- AVG Volume (30 Days)
- SNX 558.5K
- QGEN 1.4M
- Earning Date
- SNX 01-09-2026
- QGEN 11-04-2025
- Dividend Yield
- SNX 1.15%
- QGEN 3.11%
- EPS Growth
- SNX 18.98
- QGEN 331.20
- EPS
- SNX 9.21
- QGEN 1.84
- Revenue
- SNX $60,973,509,000.00
- QGEN $2,070,781,000.00
- Revenue This Year
- SNX $7.25
- QGEN $7.37
- Revenue Next Year
- SNX $4.50
- QGEN $5.65
- P/E Ratio
- SNX $16.58
- QGEN $26.41
- Revenue Growth
- SNX 6.94
- QGEN 5.32
- 52 Week Low
- SNX $92.23
- QGEN $37.63
- 52 Week High
- SNX $167.76
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- SNX 53.22
- QGEN 64.45
- Support Level
- SNX $142.22
- QGEN $43.59
- Resistance Level
- SNX $151.27
- QGEN $45.36
- Average True Range (ATR)
- SNX 3.94
- QGEN 0.77
- MACD
- SNX 0.37
- QGEN 0.54
- Stochastic Oscillator
- SNX 85.46
- QGEN 91.91
About SNX TD SYNNEX Corporation
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).